The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 47, Issue 9, Pages 1030-1037
Publisher
Springer Nature
Online
2015-08-04
DOI
10.1038/ng.3371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
- (2015) M. W. M. Kuhn et al. HAEMATOLOGICA
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
- (2015) Anna K Andersson et al. NATURE GENETICS
- MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
- (2015) M. W. M. Kuhn et al. HAEMATOLOGICA
- EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations
- (2014) Vincent-Philippe Lavallée et al. BLOOD
- Preclinical efficacy of MEK inhibition in Nras-mutant AML
- (2014) M. R. Burgess et al. BLOOD
- Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
- (2014) J. Irving et al. BLOOD
- Synergistic antiproliferative and anticholesterogenic effects of linalool, 1,8-cineole, and simvastatin on human cell lines
- (2014) Boris Rodenak Kladniew et al. CHEMICO-BIOLOGICAL INTERACTIONS
- PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
- (2014) J Zhou et al. LEUKEMIA
- Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
- (2014) N Sandhöfer et al. LEUKEMIA
- Identification of small molecules that support human leukemia stem cell activity ex vivo
- (2014) Caroline Pabst et al. NATURE METHODS
- Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
- (2014) I. Fares et al. SCIENCE
- Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
- (2013) N. Jain et al. CLINICAL CANCER RESEARCH
- Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
- (2013) K R Kampen et al. LEUKEMIA
- High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
- (2013) V Grossmann et al. LEUKEMIA
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A novel hierarchical prognostic model of AML solely based on molecular mutations
- (2012) V. Grossmann et al. BLOOD
- Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
- (2012) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search